Inventor · disambiguated record
Ehud Marom
Also filed as: MAROM EHUD
34 granted patents·11 pending applications·79 citations·filing 2009–2025
95Inventor score
Top patents by PatentIndex Score
45 records- 0191US11931357B2Depot systems comprising Cariprazine or salts thereofMAPI PHARMA LTD·Filed 2023·Granted Mar 19, 2024·2 cites·18 claims
- 0291US9006188B2Co-crystals of dapagliflozinMAPI PHARMA LTD·Filed 2014·Granted Apr 14, 2015·8 cites·15 claims
- 0390US9200114B2Random pentapolymer for treatment of autoimmune diseasesMAPI PHARMA LTD·Filed 2013·Granted Dec 1, 2015·8 cites·14 claims
- 0489US8921415B2Polymorphs of darunavirMAROM EHUD·Filed 2012·Granted Dec 30, 2014·6 cites·9 claims
- 0588US8377885B2Depot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2012·Granted Feb 19, 2013·14 cites·26 claims
- 0686USRE49251EDepot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2021·Granted Oct 18, 2022·1 cites·36 claims
- 0786US8796226B2Depot systems comprising glatiramer or a pharmacologically acceptable salt thereofMAROM EHUD·Filed 2010·Granted Aug 5, 2014·11 cites·25 claims
- 0884US11865213B2Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2021·Granted Jan 9, 2024·1 cites·19 claims
- 0982US10493122B2Sublingual delivery of glatiramer acetateMAPI PHARMA LTD·Filed 2015·Granted Dec 3, 2019·5 cites·8 claims
- 1079US11471421B2Process for preparing microparticles containing glatiramer acetateMAPI PHARMA LTD·Filed 2017·Granted Oct 18, 2022·2 cites·19 claims
- 1179US11413311B2Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cellsSTEM CELL MEDICINE LTD·Filed 2017·Granted Aug 16, 2022·2 cites·21 claims
- 1277US12251380B2Depot systems comprising cariprazine or salts thereofMAPI PHARMA LTD·Filed 2024·Granted Mar 18, 2025·0 cites·20 claims
- 1377US11167003B2Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systemsMAPI PHARMA LTD·Filed 2018·Granted Nov 9, 2021·3 cites·20 claims
- 1477US8735627B2Intermediate compounds and process for the preparation of fingolimodMAROM EHUD·Filed 2011·Granted May 27, 2014·4 cites·14 claims
- 1577US2025352607A1Glatiramer depot systems for treating progressive forms of multiple sclerosisMAPI PHARMA LTD·Filed 2025·Application pending·0 cites
- 1676US8981095B2Intermediate compounds and process for the preparation of lurasidone and salts thereofMAROM EHUD·Filed 2012·Granted Mar 17, 2015·2 cites·13 claims
- 1776US8865742B2Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodiumMAROM EHUD·Filed 2011·Granted Oct 21, 2014·3 cites·18 claims
- 1876US8410176B2Intermediate compounds and processes for the preparation of tapentadol and related compoundsMAROM EHUD·Filed 2010·Granted Apr 2, 2013·2 cites·25 claims
- 1975USRE50301EDepot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2022·Granted Feb 18, 2025·0 cites·35 claims
- 2073US9206197B2Amorphous form of dolutegravirMAROM EHUD·Filed 2012·Granted Dec 8, 2015·2 cites·14 claims
- 2171US8975244B2Process and intermediates for the preparation of abiraterone acetateMAPI PHARMA LTD·Filed 2014·Granted Mar 10, 2015·1 cites·18 claims
- 2270US12343371B2Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetateMAPI PHARMA LTD·Filed 2021·Granted Jul 1, 2025·0 cites·17 claims
- 2370US2024148653A1Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2023·Application pending·0 cites
- 2469US9453024B2Polymorphs of darunavirMAPI PHARMA LTD·Filed 2014·Granted Sep 27, 2016·0 cites·3 claims
- 2566US8841447B2Process for the preparation of alogliptinMAROM EHUD·Filed 2010·Granted Sep 23, 2014·1 cites·18 claims
- 2662US8772503B2Processes for the preparation of deferasirox, and deferasirox polymorphsMIZHIRITSKII MICHAEL·Filed 2010·Granted Jul 8, 2014·1 cites·10 claims
- 2761US12097292B2Process for preparing microparticles containing glatiramer acetateMAPI PHARMA LTD·Filed 2022·Granted Sep 24, 2024·0 cites·20 claims
- 2861US9994522B2Amorphous form of apremilastMAPI PHARMA LTD·Filed 2014·Granted Jun 12, 2018·0 cites·20 claims
- 2959US9102592B2Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodiumMAPI PHARMA LTD·Filed 2014·Granted Aug 11, 2015·0 cites·4 claims
- 3053US2014304012A1Insurance policies for stem cells depositors and methods for providing sameSTEM CELL MEDICINE LTD·Filed 2012·Application pending·0 cites
- 3152US2012035142A1Polymorphs of darunavirMAROM EHUD·Filed 2009·Application pending·0 cites
- 3251US2023256058A1Low burst-release liraglutide depot systemsMAPI PHARMA LTD·Filed 2021·Application pending·0 cites
- 3350US9096574B2Polymorphs of perampanelMAPI PHARMA LTD·Filed 2013·Granted Aug 4, 2015·0 cites·7 claims
- 3446US12370233B2Depot systems comprising glatiramer acetateMAPI PHARMA LTD·Filed 2017·Granted Jul 29, 2025·0 cites·12 claims
- 3545US2013052169A1Stem cell bank for personalized medicineMAROM EHUD·Filed 2011·Application pending·0 cites
- 3644US12161688B2Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cellsSTEM CELL MEDICINE LTD·Filed 2017·Granted Dec 10, 2024·0 cites·17 claims
- 3742US2016122709A1Stem cell bank for personalized medicineSTEM CELL MEDICINE LTD·Filed 2016·Application pending·0 cites
- 3841US11510946B2Treatment of multiple sclerosis with adipose-derived stem cellsSTEM CELL MEDICINE LTD·Filed 2018·Granted Nov 29, 2022·0 cites·10 claims
- 3941US10111867B2Process and intermediates for the preparation of perampanelMAPI PHARMA LTD·Filed 2015·Granted Oct 30, 2018·0 cites·21 claims
- 4038US2013046103A1Preparation of benzofurans and use thereof as synthetic intermediatesMAPI PHARMA LTD·Filed 2011·Application pending·0 cites
- 4138US2013059872A1Polymorphs of alogliptin benzoateMAROM EHUD·Filed 2010·Application pending·0 cites
- 4237US8829208B2Process for the preparation of darunavir and darunavir intermediatesMIZHIRITSKII MICHAEL·Filed 2011·Granted Sep 9, 2014·0 cites·25 claims
- 4337US2013225830A1Polymorphs of febuxostatMAROM EHUD·Filed 2011·Application pending·0 cites
- 4436US2014228417A1Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acidsMIZHIRITSKII MICHAEL·Filed 2012·Application pending·0 cites
- 4535US9617241B2Intermediate compounds and process for the preparation of efinaconazoleMAPI PHARMA LTD·Filed 2015·Granted Apr 11, 2017·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Ehud Marom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →